Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics

Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics

US Patent 9556280 · Granted Jan 31, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immune cell function2025
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)2025
Bispecific polypeptide complexes2023
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)2023
Monoclonal antibodies to programmed death 1 (PD-1)2022
Bispecific CD3/CD19 polypeptide complexes2022
Humanized monoclonal antibodies against activated protein c and uses thereof2022
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)2021
Filtration apparatus for use with drainage structures and method for installing 2019
Monoclonal antibodies against antithrombin beta2018
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)2018
Liquid runoff filtration system and method2018